Loading...

Peter Gray

Title(s)SRA 3, Qualcomm Institute
SchoolVc-academic Affairs
Address9500 Gilman Drive #NULL
La Jolla CA 92093
Phone000-000-NULL
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Chimeric TGF-beta Ligands for Regenerative Medicine
    NIH/NIAMS R01AR067387Aug 15, 2015 - May 31, 2020
    Role: Co-Principal Investigator
    Oncogenic Cripto Signaling in Models of Breast Cancer
    NIH/NCI R56CA107420Jun 1, 2004 - Nov 30, 2010
    Role: Principal Investigator
    Mechanisms of activin antagonism
    NIH/NICHD F32HD042362Feb 16, 2002
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles. Cancers (Basel). 2020 Jun 05; 12(6). Sousa ER, Zoni E, Karkampouna S, Manna F, Gray PC, Menna M, Julio MK. PMID: 32517087.
      View in: PubMed   Mentions:
    2. Cell surface GRP78 promotes stemness in normal and neoplastic cells. Sci Rep. 2020 02 26; 10(1):3474. Conner C, Lager TW, Guldner IH, Wu MZ, Hishida Y, Hishida T, Ruiz S, Yamasaki AE, Gilson RC, Belmonte JCI, Gray PC, Kelber JA, Zhang S, Panopoulos AD. PMID: 32103065.
      View in: PubMed   Mentions: 2     Fields:    
    3. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification. BMC Cancer. 2019 Dec 16; 19(1):1216. Zoni E, Minoli M, Bovet C, Wehrhan A, Piscuoglio S, Ng CKY, Gray PC, Spahn M, Thalmann GN, Kruithof-de Julio M. PMID: 31842810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. The Activin Receptor, Activin-Like Kinase 4, Mediates Toxoplasma Gondii Activation of Hypoxia Inducible Factor-1. Front Cell Infect Microbiol. 2019; 9:36. Lis A, Wiley M, Vaughan J, Gray PC, Blader IJ. PMID: 30891432.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Identification of myosin II as a cripto binding protein and regulator of cripto function in stem cells and tissue regeneration. Biochem Biophys Res Commun. 2019 01 29; 509(1):69-75. Hoover M, Runa F, Booker E, Diedrich JK, Duell E, Williams B, Arellano-Garcia C, Uhlendorf T, La Kim S, Fischer W, Moresco J, Gray PC, Kelber JA. PMID: 30579599.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    6. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma. J Pathol. 2018 07; 245(3):297-310. Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, Burgmans MC, Farina-Sarasqueta A, Snaar-Jagalska EB, Stroka DM, Terracciano L, van Hoek B, Schaapherder AF, Osanto S, Thalmann GN, Verspaget HW, Coenraad MJ, Kruithof-de Julio M. PMID: 29604056.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    7. Identification of Trophectoderm-Derived Cripto as an Essential Mediator of Embryo Implantation. Endocrinology. 2018 04 01; 159(4):1793-1807. Gershon E, Hadas R, Elbaz M, Booker E, Muchnik M, Kleinjan-Elazary A, Karasenti S, Genin O, Cinnamon Y, Gray PC. PMID: 29506220.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models. Front Cell Dev Biol. 2017; 5:104. Astrologo L, Zoni E, Karkampouna S, Gray PC, Klima I, Grosjean J, Goumans MJ, Hawinkels LJAC, van der Pluijm G, Spahn M, Thalmann GN, Ten Dijke P, Kruithof-de Julio M. PMID: 29259971.
      View in: PubMed   Mentions:
    9. Cripto-1: an extracellular protein - connecting the sequestered biological dots. Connect Tissue Res. 2015; 56(5):364-80. Klauzinska M, Bertolette D, Tippireddy S, Strizzi L, Gray PC, Gonzales M, Duroux M, Ruvo M, Wechselberger C, Castro NP, Rangel MC, Focà A, Sandomenico A, Hendrix MJ, Salomon D, Cuttitta F. PMID: 26327334.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    10. Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-ß-, Notch-, and Wnt-Mediated EMT. J Oncol. 2015; 2015:198967. Zoni E, van der Pluijm G, Gray PC, Kruithof-de Julio M. PMID: 25883651.
      View in: PubMed   Mentions:
    11. Engineering TGF-ß superfamily ligands for clinical applications. Trends Pharmacol Sci. 2014 Dec; 35(12):648-57. Kwiatkowski W, Gray PC, Choe S. PMID: 25458539.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    12. An activin A/BMP2 chimera, AB204, displays bone-healing properties superior to those of BMP2. J Bone Miner Res. 2014 Sep; 29(9):1950-9. Yoon BH, Esquivies L, Ahn C, Gray PC, Ye SK, Kwiatkowski W, Choe S. PMID: 24692083.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    13. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition. Semin Cancer Biol. 2014 Dec; 29:51-8. Klauzinska M, Castro NP, Rangel MC, Spike BT, Gray PC, Bertolette D, Cuttitta F, Salomon D. PMID: 25153355.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    14. Regulation of FSHß induction in LßT2 cells by BMP2 and an Activin A/BMP2 chimera, AB215. J Endocrinol. 2014 Oct; 223(1):35-45. Jung JW, Ahn C, Shim SY, Gray PC, Kwiatkowski W, Choe S. PMID: 25100748.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    15. Differential requirement of GRP94 and GRP78 in mammary gland development. Sci Rep. 2014 Jun 23; 4:5390. Zhu G, Wang M, Spike B, Gray PC, Shen J, Lee SH, Chen SY, Lee AS. PMID: 24953136.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    16. CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo. Stem Cell Reports. 2014 Apr 08; 2(4):427-39. Spike BT, Kelber JA, Booker E, Kalathur M, Rodewald R, Lipianskaya J, La J, He M, Wright T, Klemke R, Wahl GM, Gray PC. PMID: 24749068.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    17. Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. J Clin Endocrinol Metab. 2014 May; 99(5):E775-85. Islam MS, Catherino WH, Protic O, Janjusevic M, Gray PC, Giannubilo SR, Ciavattini A, Lamanna P, Tranquilli AL, Petraglia F, Castellucci M, Ciarmela P. PMID: 24606069.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    18. Designer nodal/BMP2 chimeras mimic nodal signaling, promote chondrogenesis, and reveal a BMP2-like structure. J Biol Chem. 2014 Jan 17; 289(3):1788-97. Esquivies L, Blackler A, Peran M, Rodriguez-Esteban C, Izpisua Belmonte JC, Booker E, Gray PC, Ahn C, Kwiatkowski W, Choe S. PMID: 24311780.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    19. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-?B ligand (RANKL)-induced osteoclast differentiation. J Biol Chem. 2013 Oct 25; 288(43):31299-312. Kogawa M, Hisatake K, Atkins GJ, Findlay DM, Enoki Y, Sato T, Gray PC, Kanesaki-Yatsuka Y, Anderson PH, Wada S, Kato N, Fukuda A, Katayama S, Tsujimoto M, Yoda T, Suda T, Okazaki Y, Matsumoto M. PMID: 23990468.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    20. RKIP and cytotrophoblast motility. J Cell Physiol. 2012 Dec; 227(12):3895. Ciarmela P, Marzioni D, Islam MS, Gray PC, Terracciano L, Lorenzi T, Todros T, Petraglia F, Castellucci M. PMID: 22422547.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    21. Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in vitro studies. J Cell Physiol. 2012 May; 227(5):1821-8. Ciarmela P, Marzioni D, Islam MS, Gray PC, Terracciano L, Lorenzi T, Todros T, Petraglia F, Castellucci M. PMID: 21732351.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    22. Cripto/GRP78 modulation of the TGF-ß pathway in development and oncogenesis. FEBS Lett. 2012 Jul 04; 586(14):1836-45. Gray PC, Vale W. PMID: 22306319.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    23. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011 Nov-Dec; 17(6):772-90. Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, Vale W, Castellucci M. PMID: 21788281.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    24. Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. J Clin Endocrinol Metab. 2011 Mar; 96(3):755-65. Ciarmela P, Bloise E, Gray PC, Carrarelli P, Islam MS, De Pascalis F, Severi FM, Vale W, Castellucci M, Petraglia F. PMID: 21177794.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    25. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem. 2008 Feb 22; 283(8):4490-500. Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. PMID: 18089557.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    26. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Mol Cell Biol. 2008 Jan; 28(2):666-77. Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. PMID: 17991893.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    27. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol. 2006 Dec; 26(24):9268-78. Gray PC, Shani G, Aung K, Kelber J, Vale W. PMID: 17030617.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    28. Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions. J Biol Chem. 2006 Jun 23; 281(25):17011-22. Wiater E, Harrison CA, Lewis KA, Gray PC, Vale WW. PMID: 16621788.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    29. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab. 2005 Mar; 16(2):73-8. Harrison CA, Gray PC, Vale WW, Robertson DM. PMID: 15734148.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    30. Modulation of activin and BMP signaling. Mol Cell Endocrinol. 2004 Oct 15; 225(1-2):19-24. Harrison CA, Wiater E, Gray PC, Greenwald J, Choe S, Vale W. PMID: 15451563.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    31. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors. J Biol Chem. 2004 Jul 02; 279(27):28036-44. Harrison CA, Gray PC, Fischer WH, Donaldson C, Choe S, Vale W. PMID: 15123686.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    32. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci U S A. 2003 Apr 29; 100(9):5193-8. Gray PC, Harrison CA, Vale W. PMID: 12682303.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    33. Identification of a functional binding site for activin on the type I receptor ALK4. J Biol Chem. 2003 Jun 06; 278(23):21129-35. Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W. PMID: 12665502.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    34. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol Cell Endocrinol. 2002 Feb 25; 188(1-2):254-60. Gray PC, Bilezikjian LM, Vale W. PMID: 11911962.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    Peter's Networks
    Concepts (201)
    Derived automatically from this person's publications.
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _